Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. [electronic resource]
Producer: 20180305Description: 915-932 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents -- administration & dosage
- Apoptosis -- drug effects
- Biphenyl Compounds -- administration & dosage
- Carcinoma, Hepatocellular -- metabolism
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Disease Models, Animal
- ErbB Receptors -- metabolism
- Female
- Hep G2 Cells
- Heterografts
- Humans
- Lignans -- administration & dosage
- Liver Neoplasms -- metabolism
- MAP Kinase Signaling System -- drug effects
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase 9 -- metabolism
- Melanoma, Experimental
- Mice
- Neoplasm Metastasis
- Neoplasm Staging
- Protein Stability -- drug effects
- Signal Transduction -- drug effects
- Zebrafish
- cdc42 GTP-Binding Protein -- antagonists & inhibitors
- rac1 GTP-Binding Protein -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.